THE VALUED VOICE

Physician Edition

Vol. 12, Issue 13
Click here to view past issues
Tuesday, July 9, 2024

   

WHA Offers Training to Meet MATE Act Mandates and Improve Access to Opioid and Substance Use Treatment

Many are still unaware that the DATA-2000 waiver to prescribe buprenorphine is no longer required. This change aims to remove barriers, allowing more providers to prescribe lifesaving treatments for those struggling with opioid misuse. As of June 27, 2023, the new Medication Access and Training Expansion (MATE) Act mandates that new or renewing DEA licensees complete a minimum of eight hours of training on opioid and other substance use disorders, as well as appropriate pain treatment.
 
“Incorporating training on SUD into routine health care will enable practitioners to screen more widely for substance use disorders, treat pain appropriately, prevent substance misuse and engage people in life-saving interventions.” — SAMHSA (Substance Abuse and Mental Health Services Administration)
 
The Rural Health and Substance Use Clinical Support (RHeSUS) program, a joint initiative by the Wisconsin Hospital Association and the University of Wisconsin–Madison's Program for Research, Outreach, Therapeutics, and Education in the Addictions (PROTEA), offers evidence-based training and education to fulfill the MATE Act requirements. It also provides monthly office hours for clinical support to health care professionals treating opioid and other substance use disorders. The program's content is continually updated and tailored to reflect national and Wisconsin-specific trends, ensuring it effectively supports those working with substance use disorder patients in rural Wisconsin. Participation is free of charge.
 
For information on how you can participate, click the links below or simply click the meeting links provided at the scheduled times.
 
These offerings are designed for physicians, advanced health care professionals, pharmacists and anyone on a team that offers ongoing care and support for people struggling with substance use disorders in Wisconsin and beyond.

Monthly Virtual Lunch and Learn Series - Every Third Monday of the Month
Join Webex Meeting | 12:15 – 1:15 p.m.
  • 7/15/2024 – Case presentations on hospitalized patients with Opioid Use Disorder.
  • 8/19/2024 – Resources for patients, families, and providers: identifying appropriate treatment.
Substance Use Disorder Office Hours - Every Third Tuesday of the Month
Join Zoom Meeting | 12 – 1 p.m.

Save the Dates for a Substance Use Disorders Management Boot Camp - September 19-20, 2024, in beautiful Door County, Wisconsin. More details to come!  

Medications for Opioid Use Disorder (MOUD) – Self Paced Modules
This self-paced education program, developed by Dr. Bobby Redwood, meets the MATE Act requirements. It includes six 30-minute modules covering:
  • Opioid Prescribing Best Practices
  • Alternatives to Opioids (ALTO)
  • Harm Reduction
  • Reducing Stigma and Unconscious Bias
  • MOUD in the ED
  • MOUD for Primary Care Clinicians
Funding is provided by the UW School of Medicine and Public Health from the Wisconsin Partnership Program (WPP).
 
WHA Logo
Tuesday, July 9, 2024

WHA Offers Training to Meet MATE Act Mandates and Improve Access to Opioid and Substance Use Treatment

Many are still unaware that the DATA-2000 waiver to prescribe buprenorphine is no longer required. This change aims to remove barriers, allowing more providers to prescribe lifesaving treatments for those struggling with opioid misuse. As of June 27, 2023, the new Medication Access and Training Expansion (MATE) Act mandates that new or renewing DEA licensees complete a minimum of eight hours of training on opioid and other substance use disorders, as well as appropriate pain treatment.
 
“Incorporating training on SUD into routine health care will enable practitioners to screen more widely for substance use disorders, treat pain appropriately, prevent substance misuse and engage people in life-saving interventions.” — SAMHSA (Substance Abuse and Mental Health Services Administration)
 
The Rural Health and Substance Use Clinical Support (RHeSUS) program, a joint initiative by the Wisconsin Hospital Association and the University of Wisconsin–Madison's Program for Research, Outreach, Therapeutics, and Education in the Addictions (PROTEA), offers evidence-based training and education to fulfill the MATE Act requirements. It also provides monthly office hours for clinical support to health care professionals treating opioid and other substance use disorders. The program's content is continually updated and tailored to reflect national and Wisconsin-specific trends, ensuring it effectively supports those working with substance use disorder patients in rural Wisconsin. Participation is free of charge.
 
For information on how you can participate, click the links below or simply click the meeting links provided at the scheduled times.
 
These offerings are designed for physicians, advanced health care professionals, pharmacists and anyone on a team that offers ongoing care and support for people struggling with substance use disorders in Wisconsin and beyond.

Monthly Virtual Lunch and Learn Series - Every Third Monday of the Month
Join Webex Meeting | 12:15 – 1:15 p.m.
  • 7/15/2024 – Case presentations on hospitalized patients with Opioid Use Disorder.
  • 8/19/2024 – Resources for patients, families, and providers: identifying appropriate treatment.
Substance Use Disorder Office Hours - Every Third Tuesday of the Month
Join Zoom Meeting | 12 – 1 p.m.

Save the Dates for a Substance Use Disorders Management Boot Camp - September 19-20, 2024, in beautiful Door County, Wisconsin. More details to come!  

Medications for Opioid Use Disorder (MOUD) – Self Paced Modules
This self-paced education program, developed by Dr. Bobby Redwood, meets the MATE Act requirements. It includes six 30-minute modules covering:
  • Opioid Prescribing Best Practices
  • Alternatives to Opioids (ALTO)
  • Harm Reduction
  • Reducing Stigma and Unconscious Bias
  • MOUD in the ED
  • MOUD for Primary Care Clinicians
Funding is provided by the UW School of Medicine and Public Health from the Wisconsin Partnership Program (WPP).
 

Other Articles in this Issue